Flexion Therapeutics Inc

Flexion Therapeutics — Q1 2021 Earnings Presentation

7 slides from Flexion Therapeutics's earnings presentation, Apr 13, 2021

  1. Slide 1: Q1 2021 Commercial Metrics

    Q1 2021 Commercial Metrics April 13, 2021 Exhibit 99.2

  2. Slide 2: Commercial Metrics Overview

    Commercial Metrics Overview 2 Preliminary ZILRETTA® net sales of $24.6 million in Q1 2021 4,417 accounts had purchased ZILRETTA as of March 31, 2021; up from 4,248 as of December 31, 2020 3,470 accounts had re-ordered ZILRETTA (79% of accounts that had purchased), as of March 31, 2021; up from 3,321

  3. Slide 3: ZILRETTA Net Sales Quarterly Since Launch

    ZILRETTA Net Sales Quarterly Since Launch 3 Note: Flexion recognizes ZILRETTA sales upon receipt of product by specialty distributors and pharmacies.

  4. Slide 4: Distribution of Accounts by ZILRETTA Purchases

    Distribution of Accounts by ZILRETTA Purchases Cumulative 4 Flexion primarily sells ZILRETTA to specialty distributors and a specialty pharmacy; accounts (physicians, clinics, and certain medical centers or hospitals) subsequently purchase ZILRETTA directly from these specialty distributors and the

  5. Slide 5: Distribution of ZILRETTA Purchases by Accounts

    5 Distribution of ZILRETTA Purchases by Accounts Cumulative Flexion primarily sells ZILRETTA to specialty distributors and a specialty pharmacy; accounts (physicians, clinics, and certain medical centers or hospitals) subsequently purchase ZILRETTA directly from these specialty distributors and the

  6. Slide 6: ZILRETTA Purchases by New and Existing Accounts

    ZILRETTA Purchases by New and Existing Accounts Cumulative 6 Flexion primarily sells ZILRETTA to specialty distributors and a specialty pharmacy; accounts (physicians, clinics, and certain medical centers or hospitals) subsequently purchase ZILRETTA directly from these specialty distributors and the

  7. Slide 7: Flexion: Transformative Medicine... Where It Matters

    cleion Transformative Medicine... Where It Matters

Flexion Therapeutics — Q1 2021 Earnings Presentation on 6ix